The Journal of Clinical Pediatric Rheumatology
Online ISSN : 2434-608X
Print ISSN : 2435-1105
Volume 6, Issue 1
Displaying 1-14 of 14 articles from this issue
  • Yukihiko Kawasaki
    2015 Volume 6 Issue 1 Pages 3-10
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
  • Toshinao Kawai, Nobuyuki Watanabe, Midori Yokoyama, Yumiko Nakazawa, F ...
    2015 Volume 6 Issue 1 Pages 11-16
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    Chronic granulomatous disease(CGD)is a primary immunodeficiency characterized by an inability of phagocytes to produce reactive oxygen species, resulting in recurrent life-threatening infections. Although CGD patients frequently develop inflammatory granuloma due to prolonged production of inflammatory cytokines, the treatment with corticosteroid and immunosuppressive drugs are limited because the anti-inflammation therapy for granuloma formation would increase susceptibility to infection in CGD. Herein we described two CGD patients who suffered from granulomatous interstitial pneumonia (GIP) and received thalidomide therapy for three months. Their serum level of KL-6 was high and CT lung images showed increased reticulonodular opacities. Pathological findings for GIP patient reveal inflammation and micro-granuloma formation of interstitial lung tissue, which are similar to those of hypersensitivity pneumonia. Reticulo-nodular opacities on CT image were disappeared and the KL-6 1evels were reduced after three months of thalidomide therapy in CGD patients with GIP.Although further works are required,our findings suggest that thalidomide therapy would be therapeutic effect on pulmonary inflammatory granuloma in the CGD patients.
    Download PDF (7171K)
  • Yuko Tasaki, Masaki Shimizu, Natsumi Inoue, Sayaka lshikawa, Kazuyuki ...
    2015 Volume 6 Issue 1 Pages 17-22
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    Angiopoictins(Ang)l and 2 are important regulators of endothelial cell function. To assess the role of Ang-l and 2 dysregulation in the pathogenesis of systemic juvenile idiopathic arthritis(s-JIA)associated macrophage activation syndrome(MAS), and to investigate clinical significance of serum Ang 2/l ratio in s-JIA/ MAS, we measured serum Ang l/2 1evels by enzyme-linked immunosorbent assay. Twenty five patients with s-JIA including 10 patients with MAS, 11 patients with polyarticular JIA and 15 healthy children were analyzed. Results were compared with clinical features of s-JIA. Serum Ang-l levels during MAS phase were significantly decreased compared to those during acute phase in s-JIA patients. Serum Ang 2/1 ratio during MAS phase were significantly elevated compared to those during acute phase in s-JIA patients. The Ang 2/l ratio was rapidly and extremely elevated during MAS phase, Ang 2/l ratio was also rapidly decreased after treatment. The Ang 2/l ratio correlated positively with LDH and FDP-D dimer. Serum Ang 2/l ratio levels to reflect endothelial damage might be a promising indicator of disease activity for s-JIA/MAS.
    Download PDF (5945K)
  • Masaki Shimizu, Hiroaki Umebayashi, Yuzaburo lnoue, Kazuko Kasai, Utak ...
    2015 Volume 6 Issue 1 Pages 23-27
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    Low dose weekly methotrexate(MTX)is one of the most effective drugs in the treatment for juvenile idiopathic arthritis(JIA).The purpose of the present study was to investigate the current state of MTX therapy for JIA ill Japan. A questionnaire was sent to 15 pediatricians including l2 pediatric rheumatologists in Japan. It was the most common method that starting  weekly dose was 6mg/m2 and dosage was increased to 10mg/m2 by 2mg/m2 every l - 2 weeks. Folate supplement was variably performed. Abdominal discomfort and nausea were frequently observed. The assessment of efficacy was performed after three months of treatment. The criteria for withdrawal or discontinuation of MTX therapy were variable. These results revealed that there was still a significant variation of MTX treatment among institutes in Japan. Toward the establishment of all appropriate MTX therapy,a national wide population based study is desired.
    Download PDF (4777K)
  • Akihiko Shimizu, Kaori Hisa, Shigeru Nomura, Yoshiaki Shikama, Tomoyuk ...
    2015 Volume 6 Issue 1 Pages 28-32
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    This study aimed to establish the characteristics of bone markers among pediatric patients with rheumatic diseases. We examined correlations between bone markers and bone mineral density(BMD, and evaluated the effect of glucocorticoid(GC)on their bone metabolism.58 %of the patients presented elevated bone resorption marker(TRACP-5b, and only 8 % of them presented low bone formation marker (BAP),which indicates their bone resorption is increased and formation is not suppressed. Although patients with GC therapy have Lower BMD, their bone markers are not significantly different from those without GC therapy. In addition to GC treatment, inflammatory cytokines and reduced physical activity also appear to contribute to the bone fragility. Considering pathophysiology of these patients. bisphosphonates are good candidates to prevent GC-induced osteoporosis. In conclusion, we have shown two unique aspects of bone metabolism of our patients. One is that the bone resorption is increased in more than half of the cases. The other is that the patients with GC therapy have lower BMD, but their bone markers are not significantly different from those without GC therapy. We need to collect more follow-up data to establish a basis to start bisphosphonates and to evaluate the effect of them.
    Download PDF (5803K)
  • Masaki Shimizu, Yuko Takemoto, Maiko Takakura, Natsumi Inoue, Yuko Tas ...
    2015 Volume 6 Issue 1 Pages 33-38
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    Uveitis is one of the lost important symptoms other than arthritis in juvenile idiopathic arthritis(JIA). In some cases, uveitis is refractory to anti-inflammatory treatments and can cause loss of vision. Recently, adalimumab (ADA), a monoclonal antibody against tumor necrosis factor α, has been gaining recognition as an important therapeutic modality for refractory uveitis. We report two patients with refractory JlA associated uveitis, successfully treated with ADA. Patient 1;A 2-year-old Japanese girl was referred to us with arthritis of right ankle. The diagnosis of oligo-articular JlA was made. She had uveitis. Her uveitis was refractory and oral corticosteroid was started since she was six years old. However, her uveitis subsequently became steroid dependent. ADA was initiated, following which her uveitis markedly improved. Oral corticosteroid therapy was successfully tapered. She is currently undergoing treatment with ADA, and no adverse effects have occurred. Patient 2;A 5-year-old Japanese boy was referred to us with arthritis of left knee. The diagnosis of oligo-articular JIA was lnade. He also had u、icitis. Methotrexate(MTX)and topical steroid was started and his arthritis and uveitis were improved. At the six-year of age, he suffered infectious mononucleosis and MTX treatment was stopped.His uveitis was relapsed three months later. The treatment with MTX, oral and topical corticosteroid was stated, but his uveitis subsequently became steroid dependent. ADA was initiated,following which his uveitis markedly improved. Oral corticosteroid therapy was successfully tapered. He is currently undergoing treatment with ADA. and no adverse effects have occurred, ADA is considered effective for the treatment of childhood refractory uveitis,including JIA associated uveitis. Additional indication of ADA for refractory uveitis is desired.
    Download PDF (6959K)
  • Sayaka Ishikawa, Masaki Shimizu, Natsumi Inoue, Yuko Tasaki, Kazuyuki ...
    2015 Volume 6 Issue 1 Pages 39-42
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    A20-year-old woman with undifferentiated arthritis juvenile idiopathic arthritis(JIA)developed a red excoriated plantar skin lesion at the age of 19 years. She was diagnosed with JIA at the age of l5 years. Her disease was controlled with the treatment of methotrexate and etanercept(ETA). Skin biopsy of plantar skin lesion revealed a psoriasiform hyperplasia in the epidermis. The diagnosis of psoriasiform skin lesion induced by ETA was made. There was no improvement with topical antibiotics and steroids. Because of severe skin lesions,ETA was discontinued and tocilizumab therapy was started. The skin lesions had resolved six months later. Psoriasifbrm skin lesions induced by TNF-α antagonists are rare,but pediatricians should remain aware of the possibility of psoriasis arising in JIA patients treated with TNF-α antagonists.
    Download PDF (5207K)
  • Harumi Akaike, Hiroyuki Imanaka, Yasuhito Nerome, Tomohiro Kubota, Tsu ...
    2015 Volume 6 Issue 1 Pages 43-48
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    We herein report two cases comprising three pregnancies associated with juvenile idiopathic arthritis(JIA)、  The first patient was a 31-year-old female with rheumatoid factor(RF)-positive poly-JIA and systemic lupus erythematosus. She wished to conceive at 27 years of age after undergoing successfull treatment with methotrexate and infliximab. She became pregnant after the discontinuation of these drugs;however,the arthritis flared up. At gestational week(GA)34、 she delivered a baby weighing 982g via Caesarean section due to severe intrauterine growth restriction. She subsequently conceived a second child under conditions of a moderate disease activity despite the administration of etanercept. At GA 25, she delivered a baby weighing 592g via emergent Caesarean section due to preeclampsia, The second patient was an l6-year-old female with RF positive poly-JIA. ADA was discontinued without any flare-ups when unexpected pregnancy was identified. At GA 37,she gave birth to a child weighing 2,932g.    Based on our experience, we believe that patients with JIA who are considering pregnancy or who become pregnant should achieve good control of their disease activity with an appropriate form of effective treatment, Intensive obstetric care is also required throughout pregnancy. Furthermore, Pediatric rheumatologists should be careful to check for not only psychological, but also sexual issues,in adolescent JIA patients.
    Download PDF (7114K)
  • Mao Mizuta, Kazuko Kasai, Yasuo Nakagishi, Mari Miyoshi
    2015 Volume 6 Issue 1 Pages 49-52
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
     This case is l4 years old girl who diagnosed with polyarticular juvenile idiopathic arthritis at the age of 10 years old. Rheumatoid factor and anti-cyclic citrullinated peptide antibody is positive. She has a congenital heart disease which is a common atrium, atrioventricular septal defect, absence of the inferior vena cava, and polysplenia syndrome. She was operated for two ventricular repair and mitral valve plasty at the age of l year old. At first、 we started to use the medicine of PSL and MTX, however the effect is limited for her. So we planned use of biologics (Tocilizumab). It is unknown the side effect against heart damage of using Tocilizumab. We assessed that her cardiac function was normal. Therefore we treated her with Tocilizumab. Her cardiac function remains stable. It is suggested that the use of Tocilizuinab is safe for JIA with congenital heart disease.
    Download PDF (3800K)
  • Tomomi Sato, Satoko Obayashi, Yusuke Okuda, Tomoyuki Sakai, Toshihiro ...
    2015 Volume 6 Issue 1 Pages 53-56
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    The patient ill this case was a 17-year-old girl with systemic lupus erythematosus (SLE). Ten years after onset, the SLE recurred accompanied by nephrotic syndrome. Lupus nephritis of International Society of Nephrology class lV G(A/C)was diagnosed according to kidney biopsy results. The patient underwent 4 courses of steroid pulse therapy. but her urinary protein levels gradually increased. Her systemic symptoms included marked edema and accumulation of pleuroperitoneal and pericardial fluids. She was admitted to the hospital at age 17 years 6 months. Plasmapheresis was performed to eliminate autoantibodies,which improved the nephrotic symptoms and relieved the edema and accumulated pleuroperitoneal and pericardial fluids. Thereafter,the urinary protein levels gradually decreased. Cyclophosphamide pulse therapy was selected as maintenance immunosuppression therapy. After 8 months, remission of the nephrotic syndrome was achieved、    Lupus nephritis is a serious complication of SLE, which can be a determining factor of patient quality of life and prognosis. In addition to steroids, combined use of mycophenolate mofetil and cyclophosphamide pulse therapy is necessary for the treatment of lupus nephritis class IV. In severe cases of nephrotic syndrome, plasmapheresis is considered as all effective, life-saving treatment in the acute phase.
    Download PDF (5058K)
  • Noriko Fujii, Ayaka Kitamura, Kazutaka Ouchi, Toru Morihara, Shinji Ak ...
    2015 Volume 6 Issue 1 Pages 57-61
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
    Arthritis is one of the major complications in mixed connective tissue disease (MCTD). It is mostly presented with non-erosive, mild-to-moderate synovitis. We describe a MCTD case of 14-years-old girl、who had a shoulder pain during MTX therapy for refractory constitutional symptoms at three years after onset. Arthroscopy revealed pannus formation with massive bone erosive area, which was a close resemble to synovitis in rheumatoid arthritis. She was diagnosed as MTX-resistant arthritis with MCTD and was successfully treated with synovectomy followed by tocilizumab, an effective biologics for rheumatoid arthritis. This case reminds us the importance of practical interventions based on pathophysiologic features, especially when facing multisystem disorders such as collagen diseases. Also suggests tocilizumab has a therapeutic potential for treating arthritis with collagen diseases.
    Download PDF (6822K)
  • Junya Shimizu, Yumi Ojima, Hiroki Tsuchiya, Mariko Hattori, Yuki Hyodo ...
    2015 Volume 6 Issue 1 Pages 63-67
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
     It is extremely rare that Behcet's disease arises as a complication of nephrotic syndrome(NS). The case described herein is that of a l3-year-old boy. NS onset occurred at six years old, progressing to frequently relapsing NS. However, mizoribin(MZR)high-dose therapy can achieve long-term remission. He came to repeat erythema and stomatitis from MZR high-dose therapy. Orthodontic therapy had been started. He was diagnosed as having Behcet's disease taking the ocular attack as an opportunity 7 years after NS development. Human lymphocyte antigen(HLA)typing was positive for HLA-B51.    The causes of Behcet’s disease and NS remain unclear. ln this case, therapeutic agents including steroids and MZR, as well as HLA and oral mucosal irritation, might have affected Behcet's disease development.  This extremely interesting case is useful to elucidate the pathogenic mechanism of Behcet's disease.
    Download PDF (6084K)
  • Kazuko Kasai, Mao Mizuta, Yasuo Nakagishi, Hirokazu Sakamoto, Mari Miy ...
    2015 Volume 6 Issue 1 Pages 69-72
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
     Parry-Romberg syndrome is a rare neurocutaneous syndrome characterized by slow progressive hemifacial atrophic changes. This report presents a rare case of Parry-Romberg syndrome associated with localized sclerodernia. A 7-year-old female presented with white linear atrophy of the right lower lip and a white spot on the right submaxilla. As the atrophy spread diffusely to the right cheek and submaxilla, the right half of the patient's face became deformed for 5 mollths. In parallel, the white spot lesion multiplied on the right supermaxilla, the right buccal mucosa. and the right side of the tongue. Examination of tissue from the white spot revealed infiltration of inflammatory cells and deposition of collagenous fibers in the dermis, indicating localized scleroderma. Though PRS is a rare syndrome, we should think about association with localized scleroderlna.
    Download PDF (5761K)
  • Sayaka Ishikawa, Masaki Shimizu, Natsumi Inoue, Yuko Tasaki, Kazuyuki ...
    2015 Volume 6 Issue 1 Pages 73-76
    Published: 2015
    Released on J-STAGE: December 15, 2020
    JOURNAL FREE ACCESS
     A 10-year-old girl had a right hip pain from 2 years earlier, and was referred to us with a 3-month history of pain and functional impairment in the right hip. Physical examinations were unremarkable, except of muscle wasting of her right thigh. She had severely restricted range of motion of right hips, with a flexion contracture of the right hip. Standard radiograph of the pelvis showed loss of joint space in the right hip. MRI of the hip revealed narrowing of the right hip joint space and bone marrow edema within right femoral head with cartilage loss and small volume of joint effusion with no signs of synovial thickening or enhancement which is characteristic of juvenile idiopathic arthritis(JIA). The diagnosis of idiopathic chondrolysis of hip (ICH)was made. The treatment of intra-articular corticosteroid injection followed by oral ibuprofen and physiotherapy was started. Her symptoms and standard radiograph findings improved 6 months later.    ICH is an unknown cause pediatric musculoskeletal disorder. It presents with progressive articular cartilage destruction and joint space narrowing, resulting in secondary osteoarthritis. The cardinal symptoms of lCH are strong pain of hip joint and disturbance of excursion. ICH occurs predominantly in adolescent girls, therefere, it is necessary to be differentiated from JIA.
    Download PDF (5632K)
feedback
Top